Ушбу ишга иқтибос қилган ишлар

3 та иш

Иш: Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

1. A REVIEW OF MODERN IMMUNOTHERAPY IN GASTROINTESTINAL MALIGNANT TUMORS

   A. Yusupbekov, S.V. Kamishov, A.A. Adilkhodjaev +2

   Шарҳ мақолаCancer Immunotherapy and BiomarkersEurasianUnionofScientists20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.review-article.000024

2. The combination of calreticulin-targeting L-ASNase and anti-PD-L1 antibody modulates the tumor immune microenvironment to synergistically enhance the antitumor efficacy of radiotherapy

   Ying Zhang, V. Akhil, Ho Seong Seo +8

   МақолаCancer Research and TreatmentsTheranostics20240 иқтибос

   ABIABI:AkademIndex/openalex/2024.article.000480

3. CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy

   Nada Khairi Younis, Ali Fawzi Al-Hussainy, S. Renuka Jyothi +7

   МақолаCancer Immunotherapy and BiomarkersClinical & Translational Oncology20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.002768